Management of Left-Sided Diverticulitis
Diagnosis and Initial Assessment
Obtain a CT scan with intravenous contrast in all patients with suspected acute diverticulitis to confirm the diagnosis, distinguish uncomplicated from complicated disease, and guide management decisions. 1, 2 CT achieves 98–99% sensitivity and 99–100% specificity, and clinical assessment alone misclassifies 34–68% of cases. 2
Laboratory Work-Up
- Complete blood count, C-reactive protein, and basic metabolic panel should be obtained in all patients to assess disease severity and guide risk stratification. 1, 2
- CRP >140 mg/L and WBC >15 × 10⁹/L are high-risk laboratory markers that predict progression to complicated disease. 1, 2
Disease Classification
- Uncomplicated diverticulitis: Localized colonic inflammation without abscess, perforation, fistula, obstruction, or bleeding. 1, 2, 3
- Complicated diverticulitis: Presence of abscess, perforation, fistula, obstruction, or bleeding. 1, 2
Outpatient vs. Inpatient Management
Outpatient Management Criteria (ALL Must Be Met)
Most immunocompetent patients with uncomplicated diverticulitis can be safely managed as outpatients without routine antibiotics. 1, 2, 3 This approach is supported by the DIABOLO trial (528 patients), which demonstrated that antibiotics neither accelerate recovery nor prevent complications or recurrence in uncomplicated cases. 2, 3
Outpatient eligibility requires:
- CT-confirmed uncomplicated disease (no abscess, perforation, fistula, or obstruction) 1, 2, 3
- Ability to tolerate oral fluids and medications 1, 2, 3
- Temperature <100.4°F (38°C) 2, 3
- Pain score <4/10 controlled with acetaminophen alone 2, 3
- No significant comorbidities (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes) 1, 2, 3
- Immunocompetent status 1, 2, 3
- Adequate home and social support 1, 2, 3
Outpatient management yields 35–83% cost savings per episode without compromising safety, with only 4.3% requiring subsequent hospitalization. 1, 2
Inpatient Management Indications
Hospitalize patients with any of the following:
- Complicated diverticulitis on CT (abscess ≥4–5 cm, perforation, fistula, obstruction) 1, 2, 4
- Inability to tolerate oral intake or persistent vomiting 1, 2, 4
- Signs of systemic inflammatory response or sepsis (fever, tachycardia, hypotension) 1, 2, 4
- Immunocompromised status (chemotherapy, high-dose steroids >20 mg prednisone daily, organ transplant) 1, 2, 4
- Age >80 years 1, 2
- Pregnancy 1, 2
- Significant comorbidities or frailty (ASA III–IV) 1, 2, 4
- Pain score ≥8/10 at presentation 2
Antibiotic Selection and Duration
When to Withhold Antibiotics
For immunocompetent patients with uncomplicated diverticulitis, first-line therapy is observation with supportive care (clear liquid diet, oral hydration, acetaminophen for pain) WITHOUT routine antibiotics. 1, 2, 3 The DIABOLO trial showed no benefit of antibiotics on recovery time, complication rates, or recurrence at 24-month follow-up, and hospital stays were actually shorter in the observation group (2 vs. 3 days). 2, 3
High-Risk Features Requiring Antibiotics
Reserve antibiotics for patients with ANY of the following high-risk features:
Clinical indicators:
- Persistent fever >100.4°F or chills despite supportive care 1, 2, 3
- Refractory symptoms or vomiting preventing oral hydration 1, 2, 3
- Symptom duration >5 days before presentation 1, 2, 3
Laboratory indicators:
CT imaging indicators:
- Fluid collection or abscess 1, 2, 3
- Longer segment of inflammation (>5 cm) 1, 2, 3
- Pericolic extraluminal air 1, 2, 3
Patient factors:
- Immunocompromised status (chemotherapy, high-dose steroids, organ transplant) 1, 2, 3
- Age >80 years 1, 2, 3
- Pregnancy 1, 2, 3
- ASA physical status III–IV 1, 2, 3
- Significant comorbidities (cirrhosis, CKD, heart failure, poorly controlled diabetes) 1, 2, 3
Antibiotic Regimens
Outpatient Oral Therapy (4–7 days for immunocompetent patients):
- First-line: Amoxicillin-clavulanate 875/125 mg PO twice daily 2, 3, 5
- Alternative: Ciprofloxacin 500 mg PO twice daily PLUS Metronidazole 500 mg PO three times daily 2, 3, 5
Inpatient IV Therapy (transition to oral within 48 hours when tolerated):
- Ceftriaxone PLUS Metronidazole 2, 3, 4, 5
- Piperacillin-tazobactam 2, 3, 4, 5
- Amoxicillin-clavulanate 1.2 g IV every 6 hours 2
Duration of Therapy:
- Immunocompetent patients: 4–7 days total 2, 3, 4
- Immunocompromised patients: 10–14 days total 2, 3, 4
- Post-percutaneous drainage: 4 days after adequate source control 2, 3
Transition from IV to oral antibiotics as soon as the patient tolerates oral intake (typically within 48 hours) to facilitate earlier discharge. 2, 3, 4
Management of Complicated Diverticulitis
Small Abscess (<4–5 cm)
Treat with IV antibiotics alone for 7 days. 2, 3 Hospitalization is required for close monitoring. 4
Large Abscess (≥4–5 cm)
Perform CT-guided percutaneous drainage PLUS IV antibiotics; continue antibiotics for 4 days after successful source control in immunocompetent patients. 2, 3, 4 Cultures from drainage should guide antibiotic selection. 2
Generalized Peritonitis or Sepsis
Obtain emergent surgical consultation for source control (Hartmann procedure or primary resection with anastomosis) and start broad-spectrum IV antibiotics immediately (piperacillin-tazobactam or ceftriaxone plus metronidazole). 2, 3, 4, 5
Diet Progression
Acute Phase
During the acute phase, advise a clear liquid diet for 2–3 days, then advance as symptoms improve. 2, 3 This recommendation is based primarily on patient comfort, as many patients present with anorexia and malaise. 2
If unable to advance diet after 3–5 days, immediate follow-up is required. 2
Long-Term Prevention
Recommend a high-quality diet rich in fiber (≥22 g/day) from fruits, vegetables, whole grains, and legumes, and low in red meat and sweets. 2, 3 This significantly reduces recurrence risk. 2
Do NOT restrict nuts, corn, popcorn, or small-seeded fruits—these are not associated with increased diverticulitis risk. 2, 3
Follow-Up and Monitoring
Outpatient Follow-Up
Re-evaluate all outpatients within 7 days of diagnosis (earlier if clinical status deteriorates). 2, 3, 4
Instruct patients to return immediately for:
- Fever >101°F (38.3°C) 2
- Severe uncontrolled pain 2
- Persistent vomiting 2
- Inability to eat or drink 2
- Signs of dehydration 2
If symptoms persist beyond 5–7 days despite appropriate management, obtain repeat CT imaging to assess for complications (abscess formation, perforation) rather than simply extending antibiotic duration. 2
Colonoscopy
Perform colonoscopy 6–8 weeks after symptom resolution for:
- First episode of uncomplicated diverticulitis (if no recent high-quality colonoscopy) 2, 3
- Any complicated diverticulitis (7.9% associated cancer risk) 2
- Patients ≥50 years requiring routine screening 2, 3
- Presence of alarm features (change in stool caliber, iron-deficiency anemia, rectal bleeding, weight loss) 2
Indications for Drainage or Surgery
Percutaneous Drainage
Perform CT-guided percutaneous drainage for abscesses ≥4–5 cm when feasible. 2, 3, 4 This allows conversion of urgent surgery to elective resection or avoidance of surgery altogether. 2
Surgical Consultation
Obtain surgical consultation for:
- Generalized peritonitis or septic shock 2, 3, 4
- Failed medical management after 5–7 days of appropriate antibiotics 2
- Abscess not amenable to percutaneous drainage 4
- Clinical deterioration despite medical therapy 4
- Immunocompromised patients with complicated disease 4
Elective Surgery
The decision for elective resection should be individualized based on quality of life impact, frequency of recurrence (≥3 episodes within 2 years), and patient preferences—NOT solely on the number of episodes. 2 The traditional "two-episode rule" is no longer accepted. 2
Elective sigmoidectomy reduces 5-year recurrence from 61% to 15% but carries a 10% short-term and 25% long-term complication rate. 2 The DIRECT trial demonstrated significantly better quality of life at 6 months and 5 years after elective surgery compared with continued conservative management. 2
Prevention of Recurrence
Lifestyle modifications to reduce recurrence risk:
- High-fiber diet (≥22 g/day from fruits, vegetables, whole grains, legumes) 2, 3
- Regular vigorous physical activity 2, 3
- Achieve or maintain BMI 18–25 kg/m² 2, 3
- Smoking cessation 2, 3
- Avoid nonaspirin NSAIDs when possible (aspirin is acceptable) 2, 3
Do NOT prescribe mesalamine or rifaximin for prevention—high-certainty evidence shows no benefit but increased adverse events. 2
Special Populations
Immunocompromised Patients
Immunocompromised patients require immediate antibiotic therapy (10–14 days), a lower threshold for CT imaging and repeat imaging, and early surgical consultation regardless of other factors. 2, 3, 4 They may present with milder signs despite more severe disease. 2 Corticosteroid use specifically increases the risk of perforation and death. 2
Elderly Patients (>65 Years)
Maintain a lower threshold for antibiotic treatment and closer monitoring in elderly patients, even when outpatient criteria are otherwise met. 2 Age >80 years is an absolute indication for antibiotics. 1, 2, 3
Critical Pitfalls to Avoid
- Do NOT prescribe routine antibiotics for uncomplicated diverticulitis without high-risk features—this adds antimicrobial resistance without clinical benefit. 2, 3
- Do NOT assume all diverticulitis patients need hospitalization—most immunocompetent patients with uncomplicated disease can be safely managed outpatient. 1, 2
- Do NOT discharge patients without CT confirmation of uncomplicated disease. 2, 3
- Do NOT apply the "no antibiotics" approach to complicated diverticulitis (Hinchey ≥1b with abscess)—the evidence specifically excluded these patients. 2, 3
- Do NOT stop antibiotics early when indicated—complete the full course even if symptoms improve. 2, 3
- Do NOT overlook immunocompromised patients—they require immediate antibiotics, lower threshold for imaging, and early surgical consultation. 2, 3, 4
- Do NOT unnecessarily restrict nuts, seeds, or popcorn—this is not evidence-based and may reduce overall fiber intake. 2, 3
- Do NOT delay surgical consultation in patients with frequent recurrence affecting quality of life. 2